ZA202005720B - Method for treating asthma or allergic disease - Google Patents

Method for treating asthma or allergic disease

Info

Publication number
ZA202005720B
ZA202005720B ZA2020/05720A ZA202005720A ZA202005720B ZA 202005720 B ZA202005720 B ZA 202005720B ZA 2020/05720 A ZA2020/05720 A ZA 2020/05720A ZA 202005720 A ZA202005720 A ZA 202005720A ZA 202005720 B ZA202005720 B ZA 202005720B
Authority
ZA
South Africa
Prior art keywords
allergic disease
treating asthma
asthma
treating
allergic
Prior art date
Application number
ZA2020/05720A
Other languages
English (en)
Inventor
Amine Chatila Talal
Harb Hani
Xia Mingcan
Massoud Amir
Original Assignee
Childrens Medical Ct Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Ct Corp filed Critical Childrens Medical Ct Corp
Publication of ZA202005720B publication Critical patent/ZA202005720B/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/7105Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/713Double-stranded nucleic acids or oligonucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/12Pulmonary diseases
    • G01N2800/122Chronic or obstructive airway disorders, e.g. asthma COPD
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2020/05720A 2018-03-15 2020-09-15 Method for treating asthma or allergic disease ZA202005720B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862643476P 2018-03-15 2018-03-15
US201862652630P 2018-04-04 2018-04-04
US201862659379P 2018-04-18 2018-04-18
PCT/US2019/022493 WO2019178488A1 (en) 2018-03-15 2019-03-15 Method for treating asthma or allergic disease

Publications (1)

Publication Number Publication Date
ZA202005720B true ZA202005720B (en) 2022-01-26

Family

ID=67908052

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2020/05720A ZA202005720B (en) 2018-03-15 2020-09-15 Method for treating asthma or allergic disease

Country Status (12)

Country Link
US (1) US20210278418A1 (enExample)
EP (1) EP3765025A4 (enExample)
JP (2) JP2021518345A (enExample)
KR (1) KR20200136939A (enExample)
CN (1) CN112188901A (enExample)
AU (1) AU2019236244B2 (enExample)
BR (1) BR112020018810A2 (enExample)
CA (1) CA3094143A1 (enExample)
MX (1) MX2020009496A (enExample)
RU (1) RU2020133768A (enExample)
WO (1) WO2019178488A1 (enExample)
ZA (1) ZA202005720B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230212274A1 (en) * 2020-02-21 2023-07-06 The Children's Medical Center Corporation Method for treating asthma or allergic disease
CA3182210A1 (en) * 2020-06-12 2021-12-16 Talal CHATILA Methods and compositions for treating coronavirus infectious disease
CN116473968A (zh) * 2022-01-24 2023-07-25 华中科技大学 Ezh2特异性抑制剂在治疗哮喘的用途
JP2025533355A (ja) 2022-10-05 2025-10-06 アルシーア セラピューティクス, インコーポレイテッド 気道炎症を処置するためのnotch4抗体、組成物および方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2573565A1 (en) * 2004-07-22 2006-02-02 Duska Scientific Co. Method of diagnosing, monitoring and treating pulmonary diseases
US20060211079A1 (en) * 2005-02-18 2006-09-21 Hazen Stanley L Systemic markers for asthma and analogous diseases
US7906116B2 (en) * 2005-09-01 2011-03-15 Parkash Gill Methods for using and identifying modulators of Delta-like 4
WO2007028110A2 (en) * 2005-09-01 2007-03-08 Vasgene Therapeutics, Inc. Methods for using and identifying modulators of delta-like 4
KR101535341B1 (ko) * 2012-07-02 2015-07-13 한화케미칼 주식회사 Dll4에 특이적으로 결합하는 신규한 단일클론항체 및 이의 용도
US10206941B2 (en) * 2013-07-09 2019-02-19 President And Fellows Of Harvard College Venule endothelial cell genes and uses thereof
GB201416832D0 (en) * 2014-09-24 2014-11-05 Glaxosmithkline Plc Methods of treatment
WO2019036613A1 (en) * 2017-08-18 2019-02-21 Ionis Pharmaceuticals, Inc. MODULATION OF THE NOTCH SIGNALING PATHWAY FOR THE TREATMENT OF RESPIRATORY DISORDERS

Also Published As

Publication number Publication date
EP3765025A1 (en) 2021-01-20
KR20200136939A (ko) 2020-12-08
AU2019236244A1 (en) 2020-10-22
WO2019178488A1 (en) 2019-09-19
JP2024063095A (ja) 2024-05-10
CN112188901A (zh) 2021-01-05
AU2019236244B2 (en) 2025-02-20
BR112020018810A2 (pt) 2021-02-17
MX2020009496A (es) 2021-02-26
US20210278418A1 (en) 2021-09-09
JP2021518345A (ja) 2021-08-02
EP3765025A4 (en) 2022-03-09
CA3094143A1 (en) 2019-09-19
RU2020133768A (ru) 2022-04-15

Similar Documents

Publication Publication Date Title
IL281633A (en) Methods for treating Huntington's disease
IL277333A (en) Methods for treating eye diseases
IL254768A0 (en) Method and device for treating vascular disease
ZA202005720B (en) Method for treating asthma or allergic disease
GB2567616B (en) Treatment method
IL274223A (en) Methods for treating acid-base disorders
SG10201913400QA (en) Methods for treating lung disorders
SG10202012106WA (en) Methods for treating inflammatory conditions of the lungs
IL255506A (en) A method for treating a neurological disease
IL276358A (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF ADDICTION AND RELATED DISORDERS
SG11202001806TA (en) Treatment method
GB2571601B (en) Treatment method
IL269743A (en) Methods and preparations for the treatment of disease related to the retina with CCR-3 inhibitor inventions
EP3310377A4 (en) Method of treating crohn's disease
IL276639A (en) Materials and methods for the treatment of dysproliferative diseases
PL3426237T3 (pl) Sposób leczenia zaniku mózgu
IL290770A (en) Compounds and methods for treating oxalate-related diseases
HUE049463T2 (hu) Eljárás kavicsok kezelésére
IL272977A (en) A method for treating a disease related to TNFα
SG11202105877YA (en) Method of treatment
IL275091A (en) Methods for treating Gaucher's disease
SG11202005278PA (en) Compounds for treating eye diseases and methods thereof
HK40044482A (en) Method for treating asthma or allergic disease
HK40067011A (zh) 用於治疗神经系统疾病的方法
SG11202001909TA (en) Method for treating allergic airways disease (aad)/ asthma